Search Results - "JAKUBOWSKI, CHRISTOPHER"

Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma) by Jakubowski, Christopher D., Azad, Nilofer S.

Get full text

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection by Sinha, Rileen, Winer, Andrew G., Chevinsky, Michael, Jakubowski, Christopher, Chen, Ying-Bei, Dong, Yiyu, Tickoo, Satish K., Reuter, Victor E., Russo, Paul, Coleman, Jonathan A., Sander, Chris, Hsieh, James J., Hakimi, A. Ari

“…The utility of cancer cell lines is affected by the similarity to endogenous tumour cells. Here we compare genomic data from 65 kidney-derived cell lines from…”
Get full text

Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites by Jakubowski, Christopher D., Vertosick, Emily A., Untch, Brian R., Sjoberg, Daniel, Wei, Elizabeth, Palmer, Frank L., Patel, Snehal G., Downey, Robert J., Strong, Vivian E., Russo, Paul

“…Background and Objectives Patients with metastatic RCC can undergo metastasectomy to improve survival time. Our goal was to provide and compare characteristics…”
Get full text

Subcentimeter Pulmonary Nodules are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma by Mano, Roy, Vertosick, Emily, Sankin, Alexander I, Chevinsky, Michael S, Larish, Yaniv, Jakubowski, Christopher D, Hötker, Andreas M, Hakimi, A. Ari, Sjoberg, Daniel D, Akin, Oguz, Russo, Paul

“…Purpose Renal cell carcinoma most commonly metastasizes to the lung. Indeterminate pulmonary nodules develop preoperatively in half of the patients with…”
Get full text

iTriplet, a rule-based nucleic acid sequence motif finder by Ho, Eric S, Jakubowski, Christopher D, Gunderson, Samuel I

“…With the advent of high throughput sequencing techniques, large amounts of sequencing data are readily available for analysis. Natural biological signals are…”
Get full text

Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer by Jakubowski, Christopher D., Plodkowski, Andrew J., Chang, Jason C., Rekhtman, Natasha, Iqbal, Afsheen, Paik, Paul K., Yu, Helena A.

Get full text

U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo by Goraczniak, Rafal, Wall, Brian A, Behlke, Mark A, Lennox, Kim A, Ho, Eric S, Zaphiros, Nikolas H, Jakubowski, Christopher, Patel, Neil R, Zhao, Steven, Magaway, Carlo, Subbie, Stacey A, Jenny Yu, Lumeng, LaCava, Stephanie, Reuhl, Kenneth R, Chen, Suzie, Gunderson, Samuel I

“…U1 Adaptor is a recently discovered oligonucleotide-based gene-silencing technology with a unique mechanism of action that targets nuclear pre-mRNA processing…”
Get full text

COLD AGGLUTININ DISEASE WITH NEGATIVE COLD HEMAGGLUTININ TITER IN B-CELL LYMPHOMA: A CASE REPORT by KOVALENKO, IULIIA, ALI, RIMSHA, AMIRIAN, ASLAN, GOLUBYKH, KONSTANTIN, MIRZA, TAAHA, ZARANDI, NIMA, SANGHA, LILLIAN, JAKUBOWSKI, CHRISTOPHER, TOOM, SUDHAMSHI

Get full text

A phase II trial of PD-1 inhibition with INCMGA00012 in patients with previously treated unresectable or metastatic adenosquamous pancreatic cancer by Jakubowski, Christopher, Thompson, Elizabeth D, Wang, Hao, Walker, Rosalind, Jaffee, Elizabeth M., Azad, Nilofer Saba

“…Abstract only TPS4662 Background: Adenosquamous pancreatic cancer (ASQ) constitutes 1-5% of all pancreatic cancers and compared to pancreatic adenocarcinoma…”
Get full text

Clinical and molecular features of adenosquamous pancreatic cancer (ASQ): A distinct histological subtype by Jakubowski, Christopher, Lim, Su Jin, Pellatt, Andrew, Wang, Hao, Burkhart, Richard A., Thompson, Elizabeth, Azad, Nilofer Saba

“…Abstract only 426 Background: Adenosquamous pancreatic cancers (ASQ) constitute 1-5% of all pancreatic cancers. The clinical and molecular understanding of…”
Get full text

A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal cancer by Jakubowski, Christopher, Collins, Natalie B, Sugar, Elizabeth Ann, Berg, Maureen, Cao, Haihui, Giannakis, Marios, Jaffee, Elizabeth M., Azad, Nilofer Saba

“…Abstract only TPS4114 Background: Certain somatic mutations are thought to promote immune evasion and resistance to immunotherapy. PIK3CA was identified in an…”
Get full text

Risk of venous thromboembolism, survival, and expression of procoagulant genes in neuroendocrine versus castration-resistant prostate cancer by Vlachostergios, Panagiotis J., Jakubowski, Christopher D., Lam, Linda, Christos, Paul J., Nanus, David M., Sboner, Andrea, Khani, Francesca, Beltran, Himisha, Tagawa, Scott T.

“…Abstract only…”
Get full text

Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma by Chevinsky, Michael, Imnadze, Mariam, Sankin, Alexander, Winer, Andrew, Mano, Roy, Jakubowski, Christopher, Mashni, Joseph, Sjoberg, Daniel D, Chen, Ying-Bei, Tickoo, Satish K, Reuter, Victor E, Hakimi, A. Ari, Russo, Paul

“…Purpose Tumor size and stage are important prognostic parameters in renal cell carcinoma. While pathological stage T1 and T2 are defined by size alone, the…”
Get full text

Abstract A044: Tumor-infiltrating lymphocyte density correlates with survival in pancreatic adenosquamous carcinoma by Haldar, Saurav D., Jakubowski, Christopher D., Lim, Su Jin, Wang, Hao, Burkhart, Richard A., Lafaro, Kelly, Burns, William R., He, Jin, Laheru, Daniel A., Thompson, Elizabeth D., Azad, Nilofer S.

“…Background: Pancreatic adenosquamous carcinoma (PASC) is a rare and aggressive form of pancreatic cancer, representing only 1-5% of cases. Histologically, it…”
Get full text

Abstract CT007: Phase 1/2 trial of copanlisib in combination with nivolumab for microsatellite stable (MSS) colorectal cancer (CRC) by Christenson, Eric S., Wala, Jeremiah A., Parkinson, Rose, Collins, Natalie B., Jakubowski, Christopher, Lin, Jea-Ren, Wang, Hao, Ho, Won Jin, Chan, Sabrina, Klein, Rachel, Cetasaan, Yvette, Johnson, Emma, Berg, Maureen, Meyerhardt, Jeffrey, Schlechter, Benjamin, Singh, Harshabad, Sorger, Peter K., Giannakis, Marios, Azad, Nilofer

“…Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha (PIK3CA) is frequently mutated in CRC, leading to constitutive activation and enhanced…”
Get full text

PD33-02 OVERCOMING THE OBSTACLE OF INTRATUMOR GENETIC HETEROGENEITY IN RENAL CELL CARCINOMA THROUGH ULTRA DEEP SEQUENCING OF POOLED REGIONAL TUMOR DNA by Sankin, Alex, Winer, Andrew, Hakimi, A. Ari, Wei, Elizabeth, Chevinsky, Michael, Silk, Tarik, Jakubowski, Christopher, Jacques, Fred, Durack, Jeremy, Coleman, Jonathan, Berger, Michael, Russo, Paul, Hsieh, James

Get full text

Trimodality therapy in variant urothelial carcinoma: choose wisely by Vlachostergios, Panagiotis J, Jakubowski, Christopher, Tagawa, Scott T

Get full text

Colorectal Cancer in the Young: Epidemiology, Prevention, Management by Siegel, Rebecca L, Jakubowski, Christopher Dennis, Fedewa, Stacey A, Davis, Anjee, Azad, Nilofer S

“…Colorectal cancer (CRC) incidence rates in the United States overall have declined since the mid-1980s because of changing patterns in risk factors (e.g.,…”
Get more information

Successful use of afatinib after erlotinib-induced pneumonitis in a patients with EGFR-mutant lung cancer by Jakubowski, Christopher D., MD, Plodkowski, Andrew J., MD, Chang, Jason C., MD, Rekhtman, Natasha, MD, PhD, Iqbal, Ashen, MD, Paik, Paul K., MD, Yu, Helena A., MD

Get full text

U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo by Anon

Get full text